Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Bath & Body Works Inc.
Bath & Body Works Reports 2025 Second Quarter Results and Updates Fiscal Year 2025 Guidance
Business
Aug 28 2025
13 min read

Bath & Body Works Reports 2025 Second Quarter Results and Updates Fiscal Year 2025 Guidance

news images
  • Second quarter net sales up 1.5% to $1.5 billion, at the high end of the guidance range

  • Earnings per diluted share of $0.30; adjusted earnings per diluted share of $0.37, at the high end of the guidance range

  • Full-year 2025 earnings per diluted share guidance of $3.28 to $3.53; raising the low end of adjusted earnings per diluted share guidance from $3.25 to $3.60 to $3.35 to $3.60, inclusive of current tariff rates

  • Company delivered early progress on three strategic no-regret moves to accelerate near-term growth while unlocking opportunities for consistent, durable growth

COLUMBUS, Ohio, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI) today reported second quarter 2025 results.

Daniel Heaf, chief executive officer of Bath & Body Works, commented, “Our team delivered a solid quarter, with revenue and adjusted earnings per share at the high end of our guidance range. Based on our strong first-half results and our confidence in our outlook, we are raising the low end of our full-year adjusted earnings per share guidance range.

We are moving with urgency on three no regret moves: elevating the digital experience, amplifying product efficacy, and expanding distribution to meet consumers where they are to unlock opportunities for durable long-term growth. While we still have work to do, I am energized by the focus and commitment of our teams and the opportunities in front of us.”

Second Quarter 2025 Results

The company reported net sales of $1,549 million for the quarter ended August 2, 2025, an increase of 1.5% compared to net sales of $1,526 million for the quarter ended August 3, 2024.

The company reported earnings per diluted share of $0.30 for the second quarter of 2025, compared to $0.68 last year. Second quarter operating income was $157 million compared to $183 million last year, and net income was $64 million compared to $152 million last year.

Reported second quarter 2025 results included pre-tax costs of $15 million ($14 million after-tax) associated with the transition of certain members of the leadership team. Reported second quarter 2024 results included a $39 million pre-tax gain ($25 million after-tax) related to the sales of certain Easton investments and a $44 million tax benefit related to the release of a valuation allowance on a deferred tax asset.

Excluding these items, adjusted earnings per diluted share for the second quarter of 2025 was $0.37 compared to $0.37 last year, adjusted operating income was $172 million compared to $183 million last year and adjusted net income was $78 million compared to $83 million last year.

At the conclusion of this press release is a reconciliation of reported‐to‐adjusted results, including a description of the adjusted items.

2025 Guidance

The company is narrowing its full-year 2025 net sales guidance from 1% to 3% growth to 1.5% to 2.7% growth, compared to $7,307 million in fiscal 2024. Full-year 2025 earnings per diluted share is now expected to be between $3.28 to $3.53, compared to earnings per diluted share of $3.61 in fiscal 2024. The company is raising the low end of its full-year 2025 adjusted earnings per diluted share guidance from $3.25 to $3.60 to $3.35 to $3.60, compared to adjusted earnings per diluted share of $3.29 in fiscal 2024. The company’s full-year guidance includes the anticipated impact of all tariff rates currently in effect and levied by the U.S. government and other countries. The company’s full-year guidance also includes the anticipated impact of $400 million of cash deployed towards share repurchases, which is an increase from the prior expectation of $300 million. We continue to expect to generate free cash flow of $750 million to $850 million for full-year 2025.

The company expects third quarter 2025 net sales to be up 1% to 3%, compared to $1,610 million in the third quarter of 2024. Third quarter 2025 earnings per diluted share is expected to be between $0.37 and $0.45, compared to $0.49 in the third quarter of 2024. Our third quarter 2025 outlook also includes the anticipated impact of all tariff rates as referenced above.

For a reconciliation of our reported GAAP to adjusted non-GAAP earnings per diluted share for fiscal 2024, refer to our Annual Report on Form 10-K, filed with the SEC on March 14, 2025.

Earnings Call and Additional Information

Bath & Body Works, Inc. will conduct its second quarter earnings call at 8:30 a.m. ET on August 28. To listen, call 877-407-9219 (international dial-in number: 412-652-1274). For an audio replay, call 877-660-6853 (international replay number: 201-612-7415); access code 13754889 or log onto www.BBWInc.com. A slide presentation has been posted on the company’s Investor Relations website that summarizes certain information in the company‘s prepared remarks from the earnings call as well as some additional facts and figures regarding the company’s operating performance and guidance.

ABOUT BATH & BODY WORKS

Home of America’s Favorite Fragrances®, Bath & Body Works is a global leader in personal care and home fragrance, including top-selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap. Powered by agility and innovation, the company’s predominantly U.S.-based supply chain enables it to deliver quality, on-trend luxuries at affordable prices. Bath & Body Works serves and delights customers however and wherever they want to shop, from welcoming, in-store experiences at 1,904 company-operated Bath & Body Works locations in the U.S. and Canada, 537 international franchised locations and an online storefront at bathandbodyworks.com (as of August 2, 2025).

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

We caution that any forward-looking statements (as such term is defined in the Private Securities Litigation Reform Act of 1995) contained in this press release or made by our Company or our management involve risks and uncertainties and are subject to change based on various factors, many of which are beyond our control. Accordingly, our future performance and financial results may differ materially from those expressed or implied in any such forward-looking statements. Words such as “estimate,” “project,” “plan,” “believe,” “expect,” “anticipate,” “intend,” “planned,” “potential,” “target,” “goal” and any similar expressions may identify forward-looking statements. There are risks, uncertainties and other factors that in some cases have affected and, in the future, could affect our financial performance and actual results and could cause actual results to differ materially from those expressed or implied in any forward-looking statements included in this report or otherwise made by the Company or our management. These factors can be found in Item 1A. Risk Factors in our 2024 Annual Report on Form 10-K and our subsequent filings.

We are not under any obligation and do not intend to make publicly available any update or other revisions to any of the forward-looking statements contained in this press release to reflect circumstances existing after the date of this press release or to reflect the occurrence of future events even if experience or future events make it clear that any expected results expressed or implied by those forward-looking statements will not be realized.

We announce material financial and operational information using our investor relations website, press releases, SEC filings and public conference calls and webcasts. Information about the Company, our business and our results of operations may also be announced by posts on our accounts on social media channels, including the following: Facebook, Instagram, X, LinkedIn, Pinterest, TikTok and YouTube. The information that we post through these social media channels and on our website may be deemed material. As a result, we encourage investors, the media and others interested in the Company to monitor these social media channels in addition to following our investor relations website, press releases, SEC filings and public conference calls and webcasts. The list of social media channels we use may be updated from time to time on our investor relations website.

For further information, please contact:

Bath & Body Works, Inc.:
Luke Long
InvestorRelations@bbw.com

Media Relations
Emmy Beach
Communications@bbw.com

 

BATH & BODY WORKS, INC.

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

(In millions, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

Second Quarter

 

Year-to-Date

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Net Sales

 

$

1,549

 

 

$

1,526

 

 

$

2,974

 

 

$

2,910

 

Costs of Goods Sold, Buying and Occupancy

 

 

(909

)

 

 

(900

)

 

 

(1,687

)

 

 

(1,677

)

Gross Profit

 

 

640

 

 

 

626

 

 

 

1,287

 

 

 

1,233

 

General, Administrative and Store Operating Expenses

 

 

(483

)

 

 

(443

)

 

 

(920

)

 

 

(863

)

Operating Income

 

 

157

 

 

 

183

 

 

 

367

 

 

 

370

 

Interest Expense

 

 

(68

)

 

 

(77

)

 

 

(139

)

 

 

(159

)

Other Income, Net

 

 

6

 

 

 

47

 

 

 

13

 

 

 

61

 

Income Before Income Taxes

 

 

95

 

 

 

153

 

 

 

241

 

 

 

272

 

Provision for Income Taxes

 

 

(31

)

 

 

(1

)

 

 

(72

)

 

 

(33

)

Net Income

 

$

64

 

 

$

152

 

 

$

169

 

 

$

239

 

 

 

 

 

 

 

 

 

 

Net Income per Diluted Share

 

$

0.30

 

 

$

0.68

 

 

$

0.79

 

 

$

1.06

 

 

 

 

 

 

 

 

 

 

Weighted Average Diluted Shares Outstanding

 

 

211

 

 

 

223

 

 

 

213

 

 

 

225

 


BATH & BODY WORKS, INC.

CONSOLIDATED CONDENSED BALANCE SHEETS

(Unaudited)

(In millions)

 

 

 

August 2,
2025

 

August 3,
2024

ASSETS

 

 

 

 

Current Assets:

 

 

 

 

Cash and Cash Equivalents

 

$

364

 

 

$

514

 

Accounts Receivable, Net

 

 

131

 

 

 

146

 

Inventories

 

 

977

 

 

 

863

 

Easton Assets Held for Sale

 

 

81

 

 

 

 

Other

 

 

153

 

 

 

143

 

Total Current Assets

 

 

1,706

 

 

 

1,666

 

Property and Equipment, Net

 

 

1,124

 

 

 

1,166

 

Operating Lease Assets

 

 

984

 

 

 

1,043

 

Goodwill

 

 

628

 

 

 

628

 

Trade Name

 

 

165

 

 

 

165

 

Deferred Income Taxes

 

 

133

 

 

 

143

 

Other Assets

 

 

74

 

 

 

137

 

Total Assets

 

$

4,814

 

 

$

4,948

 

LIABILITIES AND EQUITY (DEFICIT)

 

 

 

 

Current Liabilities:

 

 

 

 

Accounts Payable

 

$

567

 

 

$

411

 

Accrued Expenses and Other

 

 

541

 

 

 

526

 

Current Debt

 

 

 

 

 

313

 

Current Operating Lease Liabilities

 

 

194

 

 

 

186

 

Income Taxes

 

 

1

 

 

 

61

 

Total Current Liabilities

 

 

1,303

 

 

 

1,497

 

Deferred Income Taxes

 

 

23

 

 

 

45

 

Long-term Debt

 

 

3,888

 

 

 

3,881

 

Long-term Operating Lease Liabilities

 

 

912

 

 

 

984

 

Other Long-term Liabilities

 

 

235

 

 

 

259

 

Total Equity (Deficit)

 

 

(1,547

)

 

 

(1,718

)

Total Liabilities and Equity (Deficit)

 

$

4,814

 

 

$

4,948

 


BATH & BODY WORKS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In millions)

 

 

 

Year-to-Date

 

 

 

2025

 

 

 

2024

 

Operating Activities:

 

 

 

 

Net Income

 

$

169

 

 

$

239

 

Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:

 

 

 

 

Depreciation of Long-lived Assets

 

 

128

 

 

 

142

 

Share-based Compensation Expense

 

 

18

 

 

 

22

 

Gain on Sales of Easton Investments

 

 

 

 

 

(39

)

Deferred Income Taxes

 

 

(1

)

 

 

(102

)

Changes in Assets and Liabilities:

 

 

 

 

Accounts Receivable

 

 

75

 

 

 

78

 

Inventories

 

 

(241

)

 

 

(154

)

Accounts Payable, Accrued Expenses and Other

 

 

157

 

 

 

(67

)

Income Taxes Payable

 

 

(139

)

 

 

(79

)

Other Assets and Liabilities

 

 

(21

)

 

 

(10

)

Net Cash Provided by Operating Activities

 

 

145

 

 

 

30

 

 

 

 

 

 

Investing Activities:

 

 

 

 

Capital Expenditures

 

 

(93

)

 

 

(101

)

Proceeds from Sales of Easton Investments

 

 

 

 

 

50

 

Other Investing Activities

 

 

(2

)

 

 

11

 

Net Cash Used for Investing Activities

 

 

(95

)

 

 

(40

)

 

 

 

 

 

Financing Activities:

 

 

 

 

Payments for Long-term Debt

 

 

 

 

 

(202

)

Repurchases of Common Stock

 

 

(254

)

 

 

(248

)

Dividends Paid

 

 

(85

)

 

 

(90

)

Tax Payments related to Share-based Awards

 

 

(8

)

 

 

(15

)

Other Financing Activities

 

 

(15

)

 

 

(5

)

Net Cash Used for Financing Activities

 

 

(362

)

 

 

(560

)

 

 

 

 

 

Effects of Exchange Rate Changes on Cash and Cash Equivalents

 

 

2

 

 

 

 

Net Decrease in Cash and Cash Equivalents

 

 

(310

)

 

 

(570

)

Cash and Cash Equivalents, Beginning of Year

 

 

674

 

 

 

1,084

 

Cash and Cash Equivalents, End of Period

 

$

364

 

 

$

514

 


BATH & BODY WORKS, INC.

Second Quarter 2025

 

Total Sales (In millions):

 

 

 

 

 

 

 

Second Quarter

 

Year-to-Date

 

 

 

2025

 

 

 

2024

 

 

% Change

 

 

2025

 

 

 

2024

 

 

% Change

Stores – U.S. and Canada (a)

 

$

1,196

 

 

$

1,140

 

 

4.9

%

 

$

2,307

 

 

$

2,205

 

 

4.6

%

Direct – U.S. and Canada

 

 

267

 

 

 

297

 

 

(10.1

%)

 

 

517

 

 

 

558

 

 

(7.4

%)

International (b)

 

 

86

 

 

 

89

 

 

(2.9

%)

 

 

150

 

 

 

147

 

 

2.3

%

Total Bath & Body Works

 

$

1,549

 

 

$

1,526

 

 

1.5

%

 

$

2,974

 

 

$

2,910

 

 

2.2

%

___________________
(a)       Results include fulfilled buy online pick up in store orders.
(b)       Results include royalties associated with franchised stores and wholesale sales.


Total Company-operated Stores:

 

 

 

 

 

 

 

 

 

 

 

 

Stores

 

 

 

 

 

 

Stores

 

 

2/1/2025

 

Opened

 

Closed

 

8/2/2025

United States

 

1,782

 

 

33

 

 

(24

)

 

1,791

 

Canada

 

113

 

 

 

 

 

 

113

 

Total Bath & Body Works

 

1,895

 

 

33

 

 

(24

)

 

1,904

 


Total Partner-operated Stores:

 

 

 

 

 

 

 

 

 

 

 

 

Stores

 

 

 

 

 

 

Stores

 

 

2/1/2025

 

Opened

 

Closed

 

8/2/2025

International

 

494

 

 

25

 

 

(18

)

 

501

 

International – Travel Retail

 

35

 

 

3

 

 

(2

)

 

36

 

Total International (a)

 

529

 

 

28

 

 

(20

)

 

537

 

___________________
(a)       Includes store locations only and does not include kiosks, shop-in-shops, gondola or beauty counter locations.


BATH & BODY WORKS, INC.

ADJUSTED FINANCIAL INFORMATION

(Unaudited)

(Dollars in millions, except per share amounts)

 

 

 

 

 

 

 

 

 

 

 

Second Quarter

 

Year-to-Date

 

 

 

2025

 

 

 

2024

 

 

 

2025

 

 

 

2024

 

Reconciliation of Reported Operating Income to Adjusted Operating Income

Reported Operating Income

 

$

157

 

 

$

183

 

 

$

367

 

 

$

370

 

Leadership Transition Costs

 

 

15

 

 

 

 

 

 

15

 

 

 

 

Adjusted Operating Income

 

$

172

 

 

$

183

 

 

$

382

 

 

$

370

 

 

 

 

 

 

 

 

 

 

Reconciliation of Reported Tax Rate to Adjusted Tax Rate

Reported Tax Rate

 

 

32.3

%

 

 

0.9

%

 

 

29.9

%

 

 

12.1

%

Tax Rate Impact of Leadership Transition Costs

 

 

(3.1

)

 

 

 

 

 

(1.2

)

 

 

 

Tax Rate Impact of Gain on Sales of Easton Investments

 

 

 

 

 

(2.4

)

 

 

 

 

 

(1.3

)

Tax Rate Impact of Valuation Allowance Release

 

 

 

 

 

28.5

 

 

 

 

 

 

16.1

 

Adjusted Tax Rate

 

 

29.2

%

 

 

27.0

%

 

 

28.7

%

 

 

26.9

%

 

 

 

 

 

 

 

 

 

Reconciliation of Reported Net Income to Adjusted Net Income

Reported Net Income

 

$

64

 

 

$

152

 

 

$

169

 

 

$

239

 

Leadership Transition Costs

 

 

15

 

 

 

 

 

 

15

 

 

 

 

Gain on Sales of Easton Investments

 

 

 

 

 

(39

)

 

 

 

 

 

(39

)

Tax Effect of Adjustments

 

 

(1

)

 

 

14

 

 

 

(1

)

 

 

14

 

Tax Benefit from Valuation Allowance Release

 

 

 

 

 

(44

)

 

 

 

 

 

(44

)

Adjusted Net Income

 

$

78

 

 

$

83

 

 

$

183

 

 

$

170

 

 

 

 

 

 

 

 

 

 

Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share

Reported Net Income Per Diluted Share

 

$

0.30

 

 

$

0.68

 

 

$

0.79

 

 

$

1.06

 

Leadership Transition Costs

 

 

0.07

 

 

 

 

 

 

0.07

 

 

 

 

Gain on Sales of Easton Investments

 

 

 

 

 

(0.18

)

 

 

 

 

 

(0.18

)

Tax Effect of Adjustments

 

 

(0.01

)

 

 

0.06

 

 

 

(0.01

)

 

 

0.06

 

Tax Benefit from Valuation Allowance Release

 

 

 

 

 

(0.20

)

 

 

 

 

 

(0.19

)

Adjusted Net Income Per Diluted Share

 

$

0.37

 

 

$

0.37

 

 

$

0.86

 

 

$

0.76

 


See Notes to Adjusted Financial Information.


BATH & BODY WORKS, INC.

FORECASTED ADJUSTED FINANCIAL INFORMATION

(Unaudited)

(In millions, except per share amounts)

 

 

 

 

 

 

 

Full-Year

 

 

 

2025

 

 

 

Low

 

High

 

 

 

 

 

Reconciliation of Forecasted Net Income Per Diluted Share to Forecasted Adjusted Net Income Per Diluted Share

Forecasted Net Income Per Diluted Share

 

$

3.28

 

 

$

3.53

 

Leadership Transition Costs, Net of Tax

 

 

0.07

 

 

 

0.07

 

Forecasted Adjusted Net Income Per Diluted Share

 

$

3.35

 

 

$

3.60

 

 

 

 

 

 

Reconciliation of Forecasted Net Cash Provided by Operating Activities to Forecasted Free Cash Flow

Forecasted Net Cash Provided by Operating Activities

 

$

1,020

 

 

$

1,100

 

Forecasted Capital Expenditures

 

 

(270

)

 

 

(250

)

Forecasted Free Cash Flow

 

$

750

 

 

$

850

 


See Notes to Adjusted Financial Information.


BATH & BODY WORKS, INC.
NOTES TO ADJUSTED FINANCIAL INFORMATION
(Unaudited)

The adjusted financial information should not be construed as an alternative to the results determined in accordance with generally accepted accounting principles. Further, the company’s definitions of adjusted income information may differ from similarly titled measures used by other companies. Management believes that the presentation of adjusted financial information provides additional information to investors to facilitate the comparison of past and present operations. While it is not possible to predict future results, management believes the adjusted financial information is useful for the assessment of the operations of the company because the adjusted items are not indicative of the company’s ongoing operations due to their size and nature. Additionally, management uses adjusted financial information as key performance measures for the purpose of evaluating performance internally. The adjusted financial information should be read in conjunction with the company’s historical financial statements and notes thereto contained in the company’s Quarterly Reports on Form 10-Q and Annual Report on Form 10-K.

The “Adjusted Financial Information” provided in the attached reflects the following non-GAAP financial measures:

Fiscal 2025

In the second quarter of 2025, adjusted results excludes the following:

  • Aggregate pre-tax costs of $15 million ($14 million net of tax of $1 million), included in general, administrative and store operating expenses, due to the transition of certain members of the leadership team, primarily related to severance benefits.

There were no adjustments to results in the first quarter of 2025.

Full-year 2025 Forecasted Adjusted Net Income per Diluted Share excludes the adjustment referenced above.

Fiscal 2024

In the second quarter of 2024, adjusted results excludes the following:

  • Aggregate pre-tax gains of $39 million ($25 million net of tax of $14 million), included in other income, net, related to the sales of certain Easton investments.

  • A $44 million tax benefit related to the release of a valuation allowance on a deferred tax asset.

There were no adjustments to results in the first quarter of 2024.

Forecasted Free Cash Flow

Our Forecasted Free Cash Flow is defined as Forecasted Net Cash Provided by Operating Activities less our Forecasted Capital Expenditures. Our Forecasted Free Cash Flow is a non-GAAP financial measure which we believe is useful to analyze our anticipated ability to generate cash. Our Forecasted Free Cash Flow calculation may not be comparable to similarly-titled measures reported by other companies. Our Forecasted Free Cash Flow should be evaluated in addition to, and not considered a substitute for, other GAAP financial measures.